aspartic acid has been researched along with rolipram in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Araki, T; Chen, T; Hiranuma, T; Itoyama, Y; Kato, H; Kogure, K; Liu, XH; Murase, K | 1 |
| Dettmer, D; Hermsdorf, T; Kronbach, T; Richter, W; Unciuleac, L | 1 |
3 other study(ies) available for aspartic acid and rolipram
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Effects of chronic treatment with a cyclic AMP-selective phosphodiesterase inhibitor, rolipram, on excitatory amino acid neurotransmission systems in young and aged rat brains.
Topics: Aging; Animals; Aspartic Acid; Autoradiography; Brain; Brain Chemistry; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; GABA Agonists; Glycine; Male; Muscimol; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Wistar; Rolipram; Synaptic Transmission | 1997 |
Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Amino Acid Sequence; Amino Acid Substitution; Aspartic Acid; Binding, Competitive; Blotting, Western; Cells, Cultured; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; DNA, Complementary; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Enzymologic; Humans; Isoenzymes; Molecular Sequence Data; Mutagenesis, Site-Directed; Phosphodiesterase Inhibitors; Polymerase Chain Reaction; RNA, Messenger; Rolipram; Sequence Alignment; Substrate Specificity | 2001 |